Fibrosis Response News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fibrosis Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fibrosis Response Today - Breaking & Trending Today

Galmed reports interim results from the Open-Label part of the ARMOR study with Aramchol showing robust fibrosis improvement across multimodality histological assessment

Published: April 28, 2022

/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...

Source: prnewswire.com

Related Topics:

United StatesHebrew UniversityAllen BaharaffGalmed Pharmaceuticals LtdArtificial IntelligenceGalmed PharmaceuticalsOpen Label PartFibrosis Composite SeverityDigital PathologyFibrosis ResponseComposite ScoreGalmed Pharmaceuticals Ltd